Klotho Neurosciences Inc (KLTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,124 | -672 | -708 | -581 | -437 |
| Accounts payable and accrued liabilities | -117 | 309 | 104 | 169 | 166 |
| Other Working Capital | -133 | 363 | 261 | 234 | 171 |
| Other Operating Activity | 445 | -22 | -104 | -69 | -166 |
| Operating Cash Flow | $-929 | $-22 | $-447 | $-247 | $-265 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | -124 | -124 | 24 | -76 | -20 |
| Other Investing Activity | -124 | -124 | 24 | -76 | -20 |
| Investing Cash Flow | $-124 | $-124 | $24 | $-76 | $-20 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 950 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 175 | 175 | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | 250 | 250 | 250 |
| Other Financing Activity | 770 | 0 | 100 | 0 | 0 |
| Financing Cash Flow | $1,895 | $175 | $350 | $250 | $250 |
| Beginning Cash Position | 3 | 3 | 76 | 76 | 76 |
| End Cash Position | 845 | 32 | 3 | 2 | 40 |
| Net Cash Flow | $843 | $30 | $-73 | $-74 | $-35 |
| Free Cash Flow | |||||
| Operating Cash Flow | -929 | -22 | -447 | -247 | -265 |
| Free Cash Flow | -929 | -22 | -447 | -247 | -265 |